- IR News
- News Releases
-
- Apr. 23, 2021 (PDF/125KB)Finances
- Sumitomo Dainippon Pharma Announces Revisions to Its Financial Forecasts
-
- Apr. 13, 2021 (PDF/81KB)Products
- Urovant Sciences Announces U.S. Commercial Launch of GEMTESA (vibegron) 75 mg Tablets for Patients with Overactive Bladder
-
- Apr. 09, 2021 (PDF/113KB)CSR
- Sumitomo Dainippon Pharma Receives the "Intellectual Property Achievement Awards" for the First Time
-
- Apr. 23, 2021 (PDF/125KB)Finances
- Sumitomo Dainippon Pharma Announces Revisions to Its Financial Forecasts
-
- Apr. 13, 2021 (PDF/81KB)Products
- Urovant Sciences Announces U.S. Commercial Launch of GEMTESA (vibegron) 75 mg Tablets for Patients with Overactive Bladder
-
- Apr. 09, 2021 (PDF/113KB)CSR
- Sumitomo Dainippon Pharma Receives the "Intellectual Property Achievement Awards" for the First Time
IR Calendar
-
- May 12, 2021
- FY2020 financial results announcement (1:00pm JST)(Planned)
-
- May 13, 2021
- Analysts meeting of financial results for FY2020
-
Recommended Information Rankings
